Galectin Therapeutics GALT +53% - Wednesday morning, the company announced positive results from the Phase 1 trial of GR-MD-02.
J C Penney Company JCP +19% - Reported holiday comparable sales up 3.7%; expects Q4 same store sales at upper end of range.
Procera Networks Inc. PKT +18% - Shares are higher following better than expected fourth quarter sales results.
Frontline Ltd. FRO +10% - CNBC contributor Karen Finerman offered positive comments on Frontline.
Arena Pharmaceuticals ARNA +9.9% - The company announced positive results from its phase 1b trial evaluating APD334.
Sonic Corporation SONC +7% - The company reported financial results.
First Solar Inc. FSLR +2.5% - Shares were upgraded to Buy at Standpoint Research; upgraded to Neutral at Goldman Sachs.
KalaBios Pharmaceuticals Inc. KBIO -60% - Late Tuesday, the company reported top-line data from phase 2 study of KB001-A.
Herbalife Ltd. HLF -3% - Bill Ackman On CNBC commented on Herbalife, suggesting the company will “miss EPS massively.”
Karyopharm Therapeutics KPTI -3% - The company announced a 3 million share offering.
Five Prime Therapeutics FPRX -2.2% - Shares are lower following announcement of a 3.41 million share offering.
Micron Technology MU -2.2% - The company reported financial results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.